RHÖN-KLINIKUM AG

Notification according to section 26 para. 1 WpHG

SEB AG, Frankfurt, Germany, and Skandinaviska Enskilda Banken AB (publ), Stockholm, Sweden, notified us pursuant to section 25 para. 1 WpHG and pursuant to section 21 para. 1 WpHG of the following:

1) SEB AG, Frankfurt, Germany, notified us pursuant to section 25 para. 1 WpHG of the following:
On 7 June 2012, SEB AG exceeded the threshold of 5% of the voting rights of RHÖN-KLINIKUM AG, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, SEB AG held 7.62% of the voting rights in RHÖN-KLINIKUM AG (equals 10,539,075 voting rights). From these voting rights a proportion of 7.62% (equals 10,533,995 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 0.004% (equals 5,080 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 0.00% (equals 0 voting rights) is held indirectly. Exercise period of the instruments pursuant to section 25 WpHG is any time until cancellation / claim for the return of shares, maturity upon cancellation / claim for the return of shares.
 
2) SEB AG, Frankfurt, Germany, notified us pursuant to section 21 para. 1 WpHG of the following:
On 7 June 2012, SEB AG exceeded the threshold of 3% and 5% of the voting rights of RHÖN-KLINIKUM AG, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, SEB AG held 7.62% of the voting rights in RHÖN-KLINIKUM AG arising from 10,533,995 voting rights.

3) Skandinaviska Enskilda Banken AB (publ), Stockholm, Sweden, notified us pursuant to section 25 WpHG of the following:
On 7 June 2012, Skandinaviska Enskilda Banken AB (publ) exceeded the threshold of 5% and 10 % of the voting rights of RHÖN-KLINIKUM AG, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, SEB AG held 12.37% of the voting rights in RHÖN-KLINIKUM AG (equals 17,095,928 voting rights). From these voting rights a proportion of 7.62% (equals 10,533,995 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 4.75% (equals 6,561,933 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 0.003674% (equals 5,080 voting rights) is held indirectly (chain of controlled undertakings: SEB AG, Ulmenstraße 30, 60325 Frankfurt, Germany).  Exercise period of the instruments pursuant to section 25 WpHG is any time until cancellation / claim for the return of shares, maturity upon cancellation / claim for the return of shares.

4) Skandinaviska Enskilda Banken AB (publ), Stockholm, Sweden, notified us pursuant to section 21 para. 1 WpHG of the following:
On 7 June 2012, Skandinaviska Enskilda Banken AB (publ) exceeded the threshold of 3% and 5% of the voting rights of RHÖN-KLINIKUM AG, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Skandinaviska Enskilda Banken AB (publ) held 7.62% of the voting rights in RHÖN-KLINIKUM AG arising from 10,533,995 voting rights. All of these voting rights are attributed to Skandinaviska Enskilda Banken AB (publ) pursuant to section 22 para. 1 sent. 1 no. 1 WpHG (name of controlled undertaking: SEB AG, Germany).

Bad Neustadt a.d. Saale, 14 June 2012

The Board of Management

___________________________________________________________________